Regulation of Airway Mucin Gene Expression by Epigenetic Mechanism
表观遗传机制对气道粘蛋白基因表达的调控
基本信息
- 批准号:8050564
- 负责人:
- 金额:$ 38.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAntibodiesAsthmaAzacitidineBronchitisCell Culture TechniquesCell LineCellsChemicalsChromatinChromatin StructureChronic Obstructive Airway DiseaseClinicClinicalCloningCpG IslandsCystic FibrosisCytosineDNADNA MethylationDNA MethyltransferaseDNA Methyltransferase InhibitorDNA Modification MethylasesDeacetylationDevelopmentDiseaseEnzymesEpigenetic ProcessEpithelialEpithelial CellsGelGene ExpressionGenesGenomicsHistone AcetylationHistonesHumanHuman Cell LineIn VitroInflammatoryInterleukin-13LeadLungLung diseasesMUC5AC geneMediator of activation proteinMethylationModificationMolecular ProfilingMucinsMucociliary ClearanceMucous body substanceMusNaturePatientsPlayProductionPromoter RegionsPropertyRecoveryRegulationRegulatory PathwayRoleSmall Interfering RNASmokeSmokerSpecificitySymptomsSystemTestingTretinoinVitamin Aairway remodelingbasebisulfitecell typechromatin immunoprecipitationchromatin remodelingcytokineexpression cloninghistone modificationhuman subjectinhibitor/antagonistnon-smokernovel therapeutic interventionoverexpressionpublic health relevanceresponse
项目摘要
DESCRIPTION (provided by applicant): Mucins are major contributors to the visco-elastic properties of mucus secretion, which plays an important role in the mucociliary clearance in conducting airways. Aberrant mucus accumulation due to mucin overproduction is one of major clinical symptoms associated with various lung diseases, such as asthma, cystic fibrosis, bronchitis, chronic obstructive pulmonary diseases, etc. Significant progress has been made in the cloning, expression characterization, and the identification of mediators and regulatory pathways involved in airway mucin synthesis and secretion. However, the cell type-specificity and the persistent nature of aberrant mucin secretion in various lung patients, even following recovery, are still unclear. We hypothesize that the persistent phenomenon is related to epigenetic modification on mucin gene in addition to other modifications, such as airway remodeling and elevated presence of inflammatory cytokines in airways. Preliminary studies have shown the presence of CpG islands in the upstream promoter region of human MUC5AC (at -4,396 bp - 4,541bp), which is not present in the mouse orthologue. The level of MUC5AC expression in various human airway cell lines and primary normal bronchial epithelial (NHBE) cells are affected by the methylation status of the CpG islands. Furthermore, we showed both all-trans-retinoic acid and smoke are able to alter the methylation status of MUC5AC CpG islands and that this status is inversely related MUC5AC gene expression. Based on these results, we hypothesize that epigenetic changes, especially changes in DNA methylation status, is one of the major mechanisms involved in the persistence of mucin gene expression, especially MUC5AC. To further test this hypothesis, three specific aims are proposed. The first aim is to determine if differential MUC5AC expression in various cell lines and primary NHBE cells is regulated by epigenetic mechanisms, including changes in CpG island DNA methylation status and chromatin structure. The second aim is to address whether retinoic acid induced MUC5AC expression in cell lines, as well as in primary cells, is associated with epigenetic mechanisms that include alterations in DNA methylation status of CpG islands, and alterations in chromatin structure. The third aim is to determine if smoke-induced persistence of MUC5AC expression is associated with alterations in the DNA methylation status of CpG islands and/or chromatin structure in human subjects. To determine CpG island DNA methylation status, both bisulfite sequencing and quantitative PCR with methylated and non- methylated sequences-specific primers will be used. Chromatin immunoprecipitation (ChIP) approaches with anti-methylated deoxy-cytosine and various anti-modified histone antibodies will be used to assess DNA methylation profiles and chromatin structure of MUC5AC. Using siRNA as well as overexpression approaches, the effects of DNA methyltransferases (DNMTs) on CpG island methylation status and MUC5AC expression will be established.
PUBLIC HEALTH RELEVANCE: Aberrant airway mucin expression is a major clinical problem associated with various lung diseases; specifically, diseases airways are associated with a persistent elevation of mucin production. The nature of this persistence is unresolved. We hypothesize that epigenetic changes, especially changes in DNA methylation status and chromatin structure, are involved in the persistent elevation of MUC5AC expression in human airway cells from diseased states. We plan to identify unique molecular signatures that contribute to the regulation of MUC5AC gene expression at the epigenetic level. Understanding the unique aspects of epigenetic mechanisms involved in airway mucin gene expression will lead to a better understanding of aberrant mucin production in the airway, as well as to the development of novel therapeutic approaches to treating airway diseases.
描述(由申请人提供):粘蛋白是粘液分泌的粘弹性特性的主要贡献者,在粘膜纤毛间隙中起着重要的作用,在进行气道中起着重要作用。由于粘蛋白过量产生而导致的异常粘液积累是与各种肺部疾病有关的主要临床症状之一,例如哮喘,囊性纤维化,支气管炎,慢性阻塞性肺部疾病等。在克隆,表达,表达表达以及调解人和调节途径的鉴定方面已经取得了重大进展。然而,即使恢复后,各种肺部患者的细胞类型特异性和异常粘蛋白分泌的持续性仍然不清楚。我们假设持续现象与粘蛋白基因的表观遗传修饰有关,除了其他修饰(例如气道重塑和气道中炎性细胞因子的存在升高)。初步研究表明,在人MUC5AC的上游启动子区域(-4,396 bp -4,541bp)中存在CpG岛,这在小鼠直立同源物中不存在。在各种人类气道细胞系和原发性正常支气管上皮(NHBE)细胞中,MUC5AC表达水平受CpG岛的甲基化状态的影响。此外,我们显示了全反式近访酸和烟雾能够改变MUC5AC CpG岛的甲基化状态,并且这种状态是成反比的MUC5AC基因表达。基于这些结果,我们假设表观遗传变化,尤其是DNA甲基化状态的变化,是粘蛋白基因表达持续性,尤其是MUC5AC的主要机制之一。为了进一步检验该假设,提出了三个具体目标。第一个目的是确定在各种细胞系和原代NHBE细胞中的差异MUC5AC表达是否受到表观遗传机制的调节,包括CPG岛DNA DNA甲基化状态和染色质结构的变化。第二个目的是解决视黄酸在细胞系中以及原代细胞中诱导的MUC5AC表达是否与表观遗传机制有关,这些机制包括CPG岛DNA甲基化状态的改变以及染色质结构的改变。第三个目的是确定烟雾诱导的MUC5AC表达是否与人类受试者中CpG岛和/或染色质结构的DNA甲基化状态的改变有关。为了确定CpG岛DNA甲基化状态,将使用甲基化和非甲基化序列特异性引物的硫酸盐测序和定量PCR。染色质免疫沉淀(CHIP)方法与抗甲基化的脱氧 - 胞嘧啶和各种抗修饰的组蛋白抗体将用于评估MUC5AC的DNA甲基化谱和染色质结构。使用siRNA以及过表达方法,将建立DNA甲基转移酶(DNMT)对CpG岛甲基化状态和MUC5AC表达的影响。
公共卫生相关性:异常气道粘蛋白表达是与各种肺部疾病有关的主要临床问题;具体而言,疾病气道与粘蛋白产生的持续升高有关。这种持久性的性质尚未解决。我们假设表观遗传变化,尤其是DNA甲基化状态和染色质结构的变化,参与了患病状态的人类气道细胞中MUC5AC表达的持续升高。我们计划确定独特的分子特征,这些特征有助于在表观遗传水平上调节MUC5AC基因表达。了解气道粘蛋白基因表达中涉及的表观遗传机制的独特方面将使人们更好地了解气道中异常粘蛋白的产生,以及开发用于治疗气道疾病的新型治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Reen Wu其他文献
Reen Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Reen Wu', 18)}}的其他基金
Novel antimicrobials in fighting carbapenem-resistant Klebsiella pneumoniae
对抗耐碳青霉烯类肺炎克雷伯菌的新型抗菌药物
- 批准号:
10602594 - 财政年份:2022
- 资助金额:
$ 38.34万 - 项目类别:
Tackling the MARCKS-PIP3 Circuit to Attenuate Chronic Pulmonary Fibrosis
解决 MARCKS-PIP3 回路以减轻慢性肺纤维化
- 批准号:
10152291 - 财政年份:2021
- 资助金额:
$ 38.34万 - 项目类别:
PLASTICITY OF NON HUMAN PRIMATE TH17 CELL DIFFERENTIATION IN VITRO
非人灵长类 TH17 细胞体外分化的可塑性
- 批准号:
8357347 - 财政年份:2011
- 资助金额:
$ 38.34万 - 项目类别:
Regulation of Airway Mucin Gene Expression by Epigenetic Mechanism
表观遗传机制对气道粘蛋白基因表达的调控
- 批准号:
8247005 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
Regulation of Airway Mucin Gene Expression by Epigenetic Mechanism
表观遗传机制对气道粘蛋白基因表达的调控
- 批准号:
8451277 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
PLASTICITY OF NON HUMAN PRIMATE TH17 CELL DIFFERENTIATION IN VITRO
非人灵长类 TH17 细胞体外分化的可塑性
- 批准号:
8172630 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
Regulation of Airway Mucin Gene Expression by Epigenetic Mechanism
表观遗传机制对气道粘蛋白基因表达的调控
- 批准号:
7918317 - 财政年份:2010
- 资助金额:
$ 38.34万 - 项目类别:
Regenerative Airway Epithelium by Embryonic Stem Cells
胚胎干细胞再生气道上皮
- 批准号:
7187990 - 财政年份:2007
- 资助金额:
$ 38.34万 - 项目类别:
Regenerative Airway Epithelium by Embryonic Stem Cells
胚胎干细胞再生气道上皮
- 批准号:
7342093 - 财政年份:2007
- 资助金额:
$ 38.34万 - 项目类别:
Project 2 - Postnatal Development of Pulmonary Immune Mechanisms
项目2——产后肺部免疫机制的发育
- 批准号:
7089293 - 财政年份:2006
- 资助金额:
$ 38.34万 - 项目类别:
相似国自然基金
YTHDF3调控CXCL13表达影响黑色素瘤免疫微环境及PD-1抗体疗效的机制
- 批准号:82303866
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
AID介导抗体重链非编码区重组调控质膜BCR密度并影响记忆B细胞命运决定的研究
- 批准号:32370948
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
P29单克隆抗体的3-羟基丁酰化修饰对其稳定性影响及提升抗泡型包虫病作用的研究
- 批准号:82360402
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
心衰患者中单克隆β1-肾上腺素受体自身抗体的筛选及其对受体构象影响的研究
- 批准号:32271156
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 38.34万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 38.34万 - 项目类别:
Cellular mechanisms for the degeneration and aging of human rotator cuff tears
人类肩袖撕裂变性和衰老的细胞机制
- 批准号:
10648672 - 财政年份:2023
- 资助金额:
$ 38.34万 - 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:
10820331 - 财政年份:2023
- 资助金额:
$ 38.34万 - 项目类别: